Transforming Growth Factor-β1 and -β2 in Gastric Precancer and Cancer and Roles in Tumor-Cell Interactions with Peripheral Blood Mononuclear Cells In Vitro

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Ma, Gui Fen ^a   Miao, Qing ^a   Zeng, Xiao Qing ^a   Luo, Tian Cheng ^a   Ma, Li Li ^a   Liu, Yi Mei ^a   Lian, Jing Jing ^a   Gao, Hong ^a   Chen, Shi Yao ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; SMAD2 PROTEIN; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CELL GROWTH; CELL INTERACTION; CELL PROLIFERATION; CELL VIABILITY; COCULTURE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INHIBITION KINETICS; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PRECANCER; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; STOMACH BIOPSY; STOMACH CANCER; STOMACH SURGERY; TUMOR CELL; TUMOR GROWTH; BLOOD; CELL LINE; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; STOMACH TUMOR;

ADULT; AGED; CELL LINE; CELL PROLIFERATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; STOMACH NEOPLASMS; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2;

EID: 84872327754     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0054249     Document Type: Article

References (48)

1. Parkin DM, Bray F, Ferlay J, Pisani P, (2005) Global cancer statistics, 2002. CA Cancer J Clin. 55: 74-108.
2. Yang L, Pang Y, Moses HL, (2010) TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression. Trends Immunol. 31: 220-227.
3. Achyut BR, Yang L, (2011) Transforming growth factor-beta in the gastrointestinal and hepatic tumor microenvironment. Gastroenterology. 141: 1167-1178.
4. Massague J, (2008) TGFbeta in Cancer. Cell. 134: 215-230.
5. Vagenas K, Spyropoulos C, Gavala V, Tsamandas AC, (2007) TGFbeta1, TGFbeta2, and TGFbeta3 protein expression in gastric carcinomas: correlation with prognostics factors and patient survival. J Surg Res. 139: 182-188.
6. Laverty HG, Wakefield LM, Occleston NL, O'Kane S, Ferguson MW, (2009) TGF-beta3 and cancer: a review. Cytokine Growth Factor Rev. 20: 305-317.
7. Konrad L, Scheiber JA, Schwarz L, Schrader AJ, Hofmann R, (2009) TGF-beta1 and TGF-beta2 strongly enhance the secretion of plasminogen activator inhibitor-1 and matrix metalloproteinase-9 of the human prostate cancer cell line PC-3. Regul Pept. 155: 28-32.
8. de Caestecker MP, Piek E, Roberts AB, (2000) Role of transforming growth factor-beta signaling in cancer. J Natl Cancer Inst. 92: 1388-1402.
9. Bachman KE, Park BH, (2005) Duel nature of TGF-beta signaling: tumor suppressor vs. tumor promoter. Curr Opin Oncol. 17: 49-54.
10. Ananiev J, Gulubova M, Tchernev G, Penkova M, Miteva R, et al. (2011) Relation between transforming growth factor-beta1 expression, its receptor and clinicopathological factors and survival in HER2-negative gastric cancers. Wien Klin Wochenschr. 123: 668-673.
11. Tsamandas AC, Kardamakis D, Ravazoula P, Zolota V, Salakou S, et al. (2004) The potential role of TGFbeta1, TGFbeta2 and TGFbeta3 protein expression in colorectal carcinomas. Correlation with classic histopathologic factors and patient survival. Strahlenther Onkol. 180: 201-208.
12. Poggi A, Zocchi MR, (2006) Mechanisms of tumor escape: role of tumor microenvironment in inducing apoptosis of cytolytic effector cells. Arch Immunol Ther Exp (Warsz). 54: 323-333.
13. Taylor A, Verhagen J, Blaser K, Akdis M, Akdis CA, (2006) Mechanisms of immune suppression by interleukin-10 and transforming growth factor-beta: the role of T regulatory cells. Immunology. 117: 433-442.
14. Do TV, Kubba LA, Du H, Sturgis CD, Woodruff TK, (2008) Transforming growth factor-beta1, transforming growth factor-beta2, and transforming growth factor-beta3 enhance ovarian cancer metastatic potential by inducing a Smad3-dependent epithelial-to-mesenchymal transition. Mol Cancer Res. 6: 695-705.
15. Ono Y, Hayashida T, Konagai A, Okazaki H, Miyao K, et al. (2012) Direct inhibition of the transforming growth factor-beta pathway by protein-bound polysaccharide through inactivation of Smad2 signaling. Cancer Sci. 103: 317-324.
16. Fu H, Hu Z, Wen J, Wang K, Liu Y, (2009) TGF-beta promotes invasion and metastasis of gastric cancer cells by increasing fascin1 expression via ERK and JNK signal pathways. Acta Biochim Biophys Sin (Shanghai). 41: 648-656.
17. Beck C, Schreiber H, Rowley D, (2001) Role of TGF-beta in immune-evasion of cancer. Microsc Res Tech. 52: 387-395.
18. Li MO, Flavell RA, (2008) TGF-beta: a master of all T cell trades. Cell 134: 392-404.
19. Goumans MJ, Liu Z, Ten DP, (2009) TGF-beta signaling in vascular biology and dysfunction. Cell Res. 19: 116-127.
20. Derynck R, Zhang YE, (2003) Smad-dependent and Smad-independent pathways in TGF-beta family signaling. Nature. 425: 577-584.
21. Yannelli JR, Tucker JA, Hidalgo G, Perkins S, Kryscio R, et al. (2009) Characteristics of PBMC obtained from leukapheresis products and tumor biopsies of patients with non-small cell lung cancer. Oncol Rep. 22: 1459-1471.
22. Nowak M, Klink M, Glowacka E, Sulowska Z, Kulig A, et al. (2010) Production of cytokines during interaction of peripheral blood mononuclear cells with autologous ovarian cancer cells or benign ovarian tumour cells. Scand J Immunol. 71: 91-98.
23. Lu X, Liu J, Li H, Li W, Wang X, et al. (2011) Conversion of intratumoral regulatory T cells by human gastric cancer cells is dependent on transforming growth factor-beta1. J Surg Oncol. 104: 571-577.
24. Liu VC, Wong LY, Jang T, Shah AH, Park I, et al. (2007) Tumor evasion of the immune system by converting CD4+CD25- T cells into CD4+CD25+ T regulatory cells: role of tumor-derived TGF-beta. J Immunol. 178: 2883-2892.
25. Li X, Ye F, Chen H, Lu W, Wan X, et al. (2007) Human ovarian carcinoma cells generate CD4(+)CD25(+) regulatory T cells from peripheral CD4(+)CD25(-) T cells through secreting TGF-beta. Cancer Lett. 253: 144-153.
26. Bessler H, Djaldetti M, (2010) Role of the equilibrium between colon cancer and mononuclear cells in cytokine production. Biomed Pharmacother. 64: 706-711.
27. Hamilton SR, Aaltonen LA (2000) WHO classification of tumors pathology and genetics.Tumors of the digestive system.: IARC Press,Lyon.
28. Shen Z, Zhou S, Wang Y, Li RL, Zhong C, et al. (2010) Higher intratumoral infiltrated Foxp3+ Treg numbers and Foxp3+/CD8+ ratio are associated with adverse prognosis in resectable gastric cancer. J Cancer Res Clin Oncol. 136: 1585-1595.
29. Martignoni ME, Kunze P, Hildebrandt W, Kunzli B, Berberat P, et al. (2005) Role of mononuclear cells and inflammatory cytokines in pancreatic cancer-related cachexia. Clin Cancer Res. 11: 5802-5808.
30. Zhang Y, Wang L, Zhang M, Jin M, Bai C, et al. (2012) Potential mechanism of interleukin-8 production from lung cancer cells: an involvement of EGF-EGFR-PI3K-Akt-Erk pathway. J Cell Physiol. 227: 35-43.
31. Mabogunje OA, Subbuswamy SG, Lawrie JH, (1978) The two histological types of gastric carcinoma in Northern Nigeria. Gut. 19: 425-429.
32. Javelaud D, Alexaki VI, Dennler S, Mohammad KS, Guise TA, et al. (2011) TGF-beta/SMAD/GLI2 signaling axis in cancer progression and metastasis. Cancer Res. 71: 5606-5610.
33. Naef M, Ishiwata T, Friess H, Buchler MW, Gold LI, et al. (1997) Differential localization of transforming growth factor-beta isoforms in human gastric mucosa and overexpression in gastric carcinoma. Int J Cancer. 71: 131-137.
34. Bellone G, Gramigni C, Vizio B, Mauri FA, Prati A, et al. (2010) Abnormal expression of Endoglin and its receptor complex (TGF-beta1 and TGF-beta receptor II) as early angiogenic switch indicator in premalignant lesions of the colon mucosa. Int J Oncol. 37: 1153-1165.
35. Monteleone G, Del VBG, Palmieri G, Vavassori P, Monteleone I, et al. (2004) Induction and regulation of Smad7 in the gastric mucosa of patients with Helicobacter pylori infection. Gastroenterology. 126: 674-682.
36. Li Z, Li J, (2006) Local expressions of TGF-beta1, TGF-beta1RI, CTGF, and Smad-7 in Helicobacter pylori-associated gastritis. Scand J Gastroenterol. 41: 1007-1012.
37. Comerci JJ, Runowicz CD, Flanders KC, De Victoria C, Fields AL, et al. (1996) Altered expression of transforming growth factor-beta 1 in cervical neoplasia as an early biomarker in carcinogenesis of the uterine cervix. Cancer. 77: 1107-1114.
38. Ottaviano AJ, Sun L, Ananthanarayanan V, Munshi HG, (2006) Extracellular matrix-mediated membrane-type 1 matrix metalloproteinase expression in pancreatic ductal cells is regulated by transforming growth factor-beta1. Cancer Res. 66: 7032-7040.
39. Suda A, Saito N, Seshimo A, Kameoka S, Kobayashi M, (2009) Examination of transforming growth factor beta1 expression in the serum and tumor tissue of gastric cancer. Int Surg. 94: 182-188.
40. Li X, Yue ZC, Zhang YY, Bai J, Meng XN, et al. (2008) Elevated serum level and gene polymorphisms of TGF-beta1 in gastric cancer. J Clin Lab Anal. 22: 164-171.
41. Coban S, Yuksel O, Kockar MC, Koklu S, Basar O, et al. (2007) The significance of serum transforming growth factor beta 1 in detecting of gastric and colon cancers. Hepatogastroenterology. 54: 1472-1476.
42. Hawinkels LJ, Verspaget HW, van Duijn W, van der Zon JM, Zuidwijk K, et al. (2007) Tissue level, activation and cellular localisation of TGF-beta1 and association with survival in gastric cancer patients. Br J Cancer. 97: 398-404.
43. Lee MS, Ko SG, Kim HP, Kim YB, Lee SY, et al. (2004) Smad2 mediates Erk1/2 activation by TGF-beta1 in suspended, but not in adherent, gastric carcinoma cells. Int J Oncol. 24: 1229-1234.
44. Sekimoto G, Matsuzaki K, Yoshida K, Mori S, Murata M, et al. (2007) Reversible Smad-dependent signaling between tumor suppression and oncogenesis. Cancer Res. 67: 5090-5096.
45. Ungefroren H, Groth S, Sebens S, Lehnert H, Gieseler F, et al. (2011) Differential roles of Smad2 and Smad3 in the regulation of TGF-beta1-mediated growth inhibition and cell migration in pancreatic ductal adenocarcinoma cells: control by Rac1. Mol Cancer. 10: 67.
46. Schniewind B, Groth S, Sebens MS, Sipos B, Schafer H, et al. (2007) Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function. Oncogene. 26: 4850-4862.
47. Ten DP, Goumans MJ, Itoh F, Itoh S, (2002) Regulation of cell proliferation by Smad proteins. J Cell Physiol. 191: 1-16.
48. Reinhold D, Bank U, Buhling F, Lendeckel U, Ulmer AJ, et al. (1994) Transforming growth factor-beta 1 (TGF-beta 1) inhibits DNA synthesis of PWM-stimulated PBMC via suppression of IL-2 and IL-6 production. Cytokine. 6: 382-388.